Compare IRON & CLW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IRON | CLW |
|---|---|---|
| Founded | 2017 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Paper |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.4B | 282.8M |
| IPO Year | N/A | N/A |
| Metric | IRON | CLW |
|---|---|---|
| Price | $79.64 | $17.99 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 13 | 2 |
| Target Price | ★ $108.85 | $30.00 |
| AVG Volume (30 Days) | ★ 753.6K | 187.3K |
| Earning Date | 11-06-2025 | 02-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 875.72 |
| EPS | N/A | ★ 8.63 |
| Revenue | N/A | ★ $1,556,100,000.00 |
| Revenue This Year | N/A | $13.91 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $2.08 |
| Revenue Growth | N/A | ★ 23.00 |
| 52 Week Low | $30.82 | $16.44 |
| 52 Week High | $99.50 | $33.57 |
| Indicator | IRON | CLW |
|---|---|---|
| Relative Strength Index (RSI) | 33.29 | 48.20 |
| Support Level | $71.41 | $17.49 |
| Resistance Level | $92.00 | $19.07 |
| Average True Range (ATR) | 4.73 | 0.63 |
| MACD | -1.91 | 0.07 |
| Stochastic Oscillator | 29.60 | 32.19 |
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.
Clearwater Paper Corp is engaged in the manufacturing and supplier of Solid Bleached Sulfate (SBS) paperboard packaging products. The company products includes: SBS paperboard which is a premium paperboard grade that is frequently used to produce folding cartons, food service, commercial printing items. It generates maximum revenue from Pulp and Paperboard segment. Company operate in United States and have globalized access too. Geographically, it derives maximum revenue from the United States.